Overview

Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Current treatments for head lice include over-the-counter products such as permethrin and prescription products such as OVIDE (malathion 0.5%) lotion. In a previous phase II study, a novel, easy-to-use malathion 0.5% formulation was found to be a safe treatment for head lice. The current study will compare the efficacy and safety of this novel formulation of malathion with OVIDE and with an over-the-counter permethrin product.
Phase:
Phase 3
Details
Lead Sponsor:
Taro Pharmaceuticals USA
Treatments:
Malathion
Permethrin